- Home
- Practitioner Webinar Series
- IIH and GLP-1’s: Patient Experience
IIH and GLP-1’s: Patient Experience
March 25, 2026
This webinar explores the real-world experiences of individuals living with Idiopathic Intracranial Hypertension (IIH) who have used GLP-1 medications as part of their treatment journey.
In this session, IIH patients will share their personal stories about using GLP-1 therapies—discussing what led them to try these medications, the benefits they may have experienced, challenges or side effects they encountered, and how these treatments have impacted their day-to-day lives.
Idiopathic Intracranial Hypertension (IIH) is an underdiagnosed and undertreated disorder of elevated pressure within the brain without an identifiable cause. The IIH Practioner Series is designed for neurologists, neurosurgeons, neuro-interventionalists, endovascular surgeons, interventionist radiologists, neuroradiologists, ophthalmologists, optometrists, and ENT specialists.
Sponsored by
Novel neurovascular therapies for idiopathic intracranial hypertension (IIH)
